Clinical Trial Update: Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial is evaluating different initial doses of enarodustat tablets for anemia in non-dialysis chronic kidney disease patients; the study is not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Renal Anemia

Drugs mentioned

• Enarodustat (enarodustat)

Snippet

Sponsor: Shenzhen Salubris Pharmaceuticals Co., Ltd. | Conditions: Renal Anemia in Non-dialysis Chronic Kidney Disease | Phase 4 | Status: NOT_YET_RECRUITING